21 reports

Global Bipolar Disorder Epidemiology and Patient Flow Analysis - 2017 ##.

  • Bipolar Disorder
  • France
  • United States
  • World
  • Forecast
  • 3 Epidemiology
  • 2.3 UPCOMING RELATED REPORTS

ua=##.

  • Bipolar Disorder
  • Japan
  • United States
  • World
  • Forecast

Europe Bipolar Disorder Epidemiology and Patient Flow Analysis - 2017 ##.

  • Bipolar Disorder
  • Europe
  • France
  • Germany
  • Forecast
  • Epidemiology
  • 4 Epidemiology

Epidemiology ## Epidemiology ##. ## DISEASE BACKGROUND BIPOLAR DISORDER, ALSO KNOWN AS BIPOLAR DEPRESSION OR MANIC DEPRESSION, IS A PSYCHOLOGICAL DISORDER THAT PRESENTS WITH SEVERE SHIFTS IN MOOD FROM ONE EXTREME TO ANOTHER.

  • Bipolar Disorder
  • World
  • Market Size
  • AstraZeneca PLC
  • Otsuka Pharmaceutical Co., Ltd.

Bipolar Disorder Phase ## Clinical Trials, 2016 ##.

  • Bipolar Disorder
  • France
  • United States
  • Market Shares
  • Market Size

& nbsp; Forecasted growth in the total prevalence of bipolar I disorder and bipolar II disorder will be driven by demographics.

  • Bipolar Disorder
  • European Union
  • Japan
  • United States
  • Demand

Bipolar Disorder Phase ## Clinical Trials, 2016 ##.

  • Bipolar Disorder
  • France
  • Germany
  • Market Shares
  • Market Size
  • EPIDEMIOLOGY
  • Epidemiology: Bipolar Disorder in the US, Japan, and 5EU

Clinical Practice and Epidemiology in Mental Health, ##(##), ##.

  • Bipolar Disorder
  • North America
  • United States
  • AstraZeneca PLC
  • Eli Lilly & Co.

Bipolar Disorder Phase ## Clinical Trials, 2016 ##.

  • Bipolar Disorder
  • Mental Health
  • Japan
  • Market Shares
  • Market Size

Bipolar Disorder Phase ## Clinical Trials, 2016 ##.

  • Bipolar Disorder
  • Mental Health
  • United States
  • Market Shares
  • Market Size

Bipolar Disorder Phase ## Clinical Trials, 2016 ##.

  • Bipolar Disorder
  • Mental Health
  • United Kingdom
  • Market Shares
  • Market Size

Bipolar Disorder Phase ## Clinical Trials, 2016 ##.

  • Bipolar Disorder
  • Mental Health
  • Italy
  • Market Shares
  • Market Size

Bipolar Disorder Phase ## Clinical Trials, 2016 ##.

  • Bipolar Disorder
  • Mental Health
  • France
  • Market Shares
  • Market Size

Bipolar Disorder Phase ## Clinical Trials, 2016 ##.

  • Bipolar Disorder
  • Mental Health
  • Germany
  • Market Shares
  • Market Size

Bipolar Disorder Phase ## Clinical Trials, 2016 ##.

  • Bipolar Disorder
  • Mental Health
  • Spain
  • Market Shares
  • Market Size
  • COUNTRY PROFILE - JAPAN
  • 9.3 METHODOLOGY

Clinical Practice and Epidemiology in Mental Health; ##(##).

  • Bipolar Disorder
  • World
  • Forecast
  • Eli Lilly & Co.
  • Otsuka Pharmaceutical Co., Ltd.
  • 5.3 METHODOLOGY
  • 5.1 BIBLIOGRAPHY

CLINICAL PRACTICE AND EPIDEMIOLOGY IN MENTAL HEALTH; ##(##).

  • Bipolar Disorder
  • Allergan plc
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • Janssen Biotech, Inc.
  • Disease Management
  • 9.3 METHODOLOGY

Clinical Practice and Epidemiology in Mental Health; ##(##).

  • Bipolar Disorder
  • World
  • Forecast
  • Eli Lilly & Co.
  • Otsuka Pharmaceutical Co., Ltd.
  • COUNTRY PROFILE - US
  • 9.3 METHODOLOGY

Clinical Practice and Epidemiology in Mental Health; ##(##).

  • Bipolar Disorder
  • World
  • Forecast
  • Eli Lilly & Co.
  • Otsuka Pharmaceutical Co., Ltd.
  • COUNTRY PROFILE - CANADA
  • 9.3 METHODOLOGY

Clinical Practice and Epidemiology in Mental Health; ##(##).

  • Bipolar Disorder
  • World
  • Forecast
  • Eli Lilly & Co.
  • Otsuka Pharmaceutical Co., Ltd.
  • Disease overview

In this condition individuals experience one or more depressive episodes followed by at least one episode of hypomania.

  • Bipolar Disorder
  • Allergan plc
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • Janssen Biotech, Inc.